Working… Menu

Autologous Adipose-derived Stem Cells (AdMSCs) for COVID-19

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04428801
Recruitment Status : Not yet recruiting
First Posted : June 11, 2020
Last Update Posted : November 9, 2020
Information provided by (Responsible Party):
Celltex Therapeutics Corporation

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : January 10, 2022
Estimated Study Completion Date : January 10, 2024